|
ES2328446T5
(es)
|
2000-02-04 |
2014-02-27 |
Children's Hospital Research Foundation |
Uso de lipasa ácida lisosomal para tratar la aterosclerosis y enfermedades asociadas
|
|
US20100183558A1
(en)
|
2008-10-17 |
2010-07-22 |
Zhennan Lai |
Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules
|
|
MX338426B
(es)
|
2010-04-23 |
2016-04-15 |
Synageva Biopharma Corp |
Enzima de enfermedad del almacenamiento lisosomico.
|
|
US9309534B2
(en)
|
2010-07-12 |
2016-04-12 |
Universidad Autonoma De Barcelona |
Gene therapy composition for use in diabetes treatment
|
|
CA2807552A1
(en)
|
2010-08-06 |
2012-02-09 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
DK2613798T4
(en)
|
2010-09-09 |
2018-04-16 |
Synageva Biopharma Corp |
USING LYSOSOMAL SUR LIPASE TO TREAT PATIENTS WITHOUT LYSOSOMAL SUR LIPASE
|
|
ES3005233T3
(en)
|
2010-10-01 |
2025-03-14 |
Modernatx Inc |
Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
|
|
EP2675472A4
(en)
|
2011-02-15 |
2014-09-17 |
Synageva Biopharma Corp |
METHOD FOR THE TREATMENT OF LACK OF LYSOSOMAL SAURER LIPASE
|
|
US8865881B2
(en)
|
2011-02-22 |
2014-10-21 |
California Institute Of Technology |
Delivery of proteins using adeno-associated virus (AAV) vectors
|
|
JP2014511687A
(ja)
|
2011-03-31 |
2014-05-19 |
モデルナ セラピューティクス インコーポレイテッド |
工学操作された核酸の送達および製剤
|
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
EP2763701B1
(en)
|
2011-10-03 |
2018-12-19 |
Moderna Therapeutics, Inc. |
Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
|
|
JP2015501844A
(ja)
|
2011-12-16 |
2015-01-19 |
モデルナ セラピューティクス インコーポレイテッドＭｏｄｅｒｎａ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． |
修飾ヌクレオシド、ヌクレオチドおよび核酸組成物
|
|
US10093947B2
(en)
*
|
2012-02-28 |
2018-10-09 |
Cornell University |
AAV-directed persistent expression of an anti-nicotine antibody gene for smoking cessation
|
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
|
US9254311B2
(en)
|
2012-04-02 |
2016-02-09 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of proteins
|
|
WO2013151663A1
(en)
|
2012-04-02 |
2013-10-10 |
modeRNA Therapeutics |
Modified polynucleotides for the production of membrane proteins
|
|
US10004811B2
(en)
*
|
2012-04-13 |
2018-06-26 |
Cornell University |
Development of a highly efficient second generation nicotine-conjugate vaccine to treat nicotine addiction
|
|
EP2900275A4
(en)
|
2012-09-29 |
2016-05-25 |
Univ Pennsylvania |
VETERINARY COMPOSITION AND METHOD FOR NONOPERATIVE CASTRATION
|
|
EP2914731B1
(en)
*
|
2012-11-01 |
2019-09-11 |
California Institute of Technology |
Reversible gene expression
|
|
ES2921623T3
(es)
|
2012-11-26 |
2022-08-30 |
Modernatx Inc |
ARN modificado terminalmente
|
|
KR20230156146A
(ko)
*
|
2012-12-13 |
2023-11-13 |
더 트러스티스 오브 더 유니버시티 오브 펜실베니아 |
Ｄｎａ 항체 작제물 및 그 이용 방법
|
|
WO2015089492A2
(en)
|
2013-12-13 |
2015-06-18 |
The Trustees Of The University Of Pennsylvania |
Dna antibody constructs and method of using same
|
|
WO2014120975A1
(en)
|
2013-02-01 |
2014-08-07 |
California Institute Of Technology |
Antibody-mediated immunocontraception
|
|
US11332719B2
(en)
|
2013-03-15 |
2022-05-17 |
The Broad Institute, Inc. |
Recombinant virus and preparations thereof
|
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
|
US9597658B2
(en)
|
2013-04-01 |
2017-03-21 |
Savannah River Nuclear Solutions, Llc |
Metal-organic framework templated synthesis of porous inorganic materials as novel sorbents
|
|
US10006049B2
(en)
*
|
2013-05-16 |
2018-06-26 |
University Of Florida Research Foundation, Incorporated |
Hairpin mRNA elements and methods for the regulation of protein translation
|
|
WO2015048744A2
(en)
|
2013-09-30 |
2015-04-02 |
Moderna Therapeutics, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
|
KR20160067219A
(ko)
|
2013-10-03 |
2016-06-13 |
모더나 세라퓨틱스, 인코포레이티드 |
저밀도 지단백질 수용체를 암호화하는 폴리뉴클레오타이드
|
|
US9884075B2
(en)
|
2014-01-16 |
2018-02-06 |
California Institute Of Technology |
Domain-swap T cell receptors
|
|
MX392639B
(es)
|
2014-03-21 |
2025-03-24 |
Univ Leland Stanford Junior |
Vectores virales recombinantes para la integración de transgenes
|
|
MY186389A
(en)
*
|
2014-05-13 |
2021-07-22 |
Univ Pennsylvania |
Compositions comprising aav expressing dual antibody constructs and uses thereof
|
|
CN107043774B
(zh)
*
|
2014-09-25 |
2021-05-04 |
中国人民解放军第二军医大学东方肝胆外科医院 |
一种嵌合强启动子及其用途
|
|
CN107106689A
(zh)
*
|
2014-11-05 |
2017-08-29 |
沃雅戈治疗公司 |
用于治疗帕金森病的aadc多核苷酸
|
|
CN112410338A
(zh)
|
2014-11-14 |
2021-02-26 |
沃雅戈治疗公司 |
调节性多核苷酸
|
|
BR112017011556A2
(en)
|
2014-12-01 |
2018-03-06 |
The Trustees Of The University Of Pennsylvania |
methods for generating a synthetic antibody, preventing or treating a disease, treating a subject of pathogen infection and a subject with cancer, product, nucleic acid molecule, and composition.
|
|
EP3242945B1
(en)
|
2015-01-07 |
2021-09-01 |
Universitat Autònoma de Barcelona |
Single-vector gene construct comprising insulin and glucokinase genes
|
|
US11000597B2
(en)
*
|
2015-01-21 |
2021-05-11 |
University Of Florida Research Foundation, Incorporated |
Engineered receptor/ligand system for delivery of therapeutic agents
|
|
WO2016122791A1
(en)
|
2015-01-30 |
2016-08-04 |
The Regents Of The University Of California |
Spinal subpial gene delivery system
|
|
EP3283126B1
(en)
|
2015-04-16 |
2019-11-06 |
Emory University |
Recombinant promoters and vectors for protein expression in liver and use thereof
|
|
CN107708416B
(zh)
|
2015-05-01 |
2021-06-29 |
Onl医疗股份有限公司 |
肽组合物和使用方法
|
|
EP4154914B1
(en)
*
|
2015-05-07 |
2024-08-28 |
University of South Florida |
Modified ube3a gene for a gene therapy approach for angelman syndrome
|
|
EA201792500A1
(ru)
|
2015-05-13 |
2018-04-30 |
Дзе Трастиз Оф Дзе Юниверсити Оф Пенсильвания |
Aav-опосредованная экспрессия антител против гриппа и способы их использования
|
|
US10016514B2
(en)
|
2015-05-15 |
2018-07-10 |
New Hope Research Foundation |
Polynucleotides, vectors and methods for insertion and expression of transgenes
|
|
US10966414B2
(en)
|
2015-05-26 |
2021-04-06 |
California Institute Of Technology |
Population control using engineered translocations
|
|
WO2017007994A1
(en)
|
2015-07-08 |
2017-01-12 |
American Gene Technologies International Inc. |
Hiv pre-immunization and immunotherapy
|
|
US10266844B2
(en)
|
2015-07-31 |
2019-04-23 |
California Institute Of Technology |
Activity-dependent expression of nucleic acids
|
|
EP3875593A1
(en)
|
2015-12-11 |
2021-09-08 |
California Institute of Technology |
Targeting peptides for directing adeno-associated viruses (aavs)
|
|
CN111569090A
(zh)
|
2016-01-15 |
2020-08-25 |
美国基因技术国际有限公司 |
用于活化γ-δ T细胞的方法和组合物
|
|
US10137144B2
(en)
|
2016-01-15 |
2018-11-27 |
American Gene Technologies International Inc. |
Methods and compositions for the activation of gamma-delta T-cells
|
|
JP7153332B2
(ja)
|
2016-02-08 |
2022-10-14 |
アメリカン ジーン テクノロジーズ インターナショナル インコーポレイテッド |
Ｈｉｖワクチン接種および免疫療法
|
|
ES2911448T3
(es)
|
2016-03-09 |
2022-05-19 |
American Gene Tech Int Inc |
Vectores combinados y métodos para el tratamiento del cáncer
|
|
US20230279434A1
(en)
*
|
2016-03-31 |
2023-09-07 |
University Of Cincinnati |
Methods and compositions for the treatment of als
|
|
WO2017180936A1
(en)
*
|
2016-04-15 |
2017-10-19 |
The Trustees Of The University Of Pennsylvania |
Compositions for treatment of wet age-related macular degeneration
|
|
US11326182B2
(en)
|
2016-04-29 |
2022-05-10 |
Voyager Therapeutics, Inc. |
Compositions for the treatment of disease
|
|
US20190224339A1
(en)
*
|
2016-04-29 |
2019-07-25 |
Voyager Therapeutics, Inc. |
Compositions for the treatment of disease
|
|
WO2017189964A2
(en)
|
2016-04-29 |
2017-11-02 |
Voyager Therapeutics, Inc. |
Compositions for the treatment of disease
|
|
US11976292B2
(en)
|
2016-06-08 |
2024-05-07 |
American Gene Technologies International Inc. |
Non-integrating viral delivery system and methods related thereto
|
|
EP3481418A4
(en)
|
2016-07-08 |
2020-03-11 |
American Gene Technologies International Inc. |
PRE-IMMUNIZATION AND IMMUNOTHERAPY OF HIV
|
|
US11583562B2
(en)
|
2016-07-21 |
2023-02-21 |
American Gene Technologies International Inc. |
Viral vectors for treating Parkinson's disease
|
|
KR102621134B1
(ko)
*
|
2016-07-26 |
2024-01-04 |
코넬 유니버시티 |
알데히드 데히드로게나제 결핍의 치료를 위한 유전자 요법
|
|
CN106434575A
(zh)
*
|
2016-09-26 |
2017-02-22 |
中国动物卫生与流行病学中心 |
流感病毒作为表达载体的构建方法
|
|
AU2017336440B2
(en)
|
2016-09-28 |
2022-06-02 |
Cohbar, Inc. |
Therapeutic MOTS-c related peptides
|
|
EP3518966A1
(en)
|
2016-09-29 |
2019-08-07 |
GlaxoSmithKline Biologicals S.A. |
Compositions and methods of treatment of persistent hpv infection
|
|
EP3538546B1
(en)
|
2016-11-14 |
2025-01-08 |
Novartis AG |
Compositions, methods, and therapeutic uses related to fusogenic protein minion
|
|
GB201620968D0
(en)
|
2016-12-09 |
2017-01-25 |
Glaxosmithkline Biologicals Sa |
Adenovirus polynucleotides and polypeptides
|
|
CN110036020A
(zh)
|
2016-12-09 |
2019-07-19 |
葛兰素史密丝克莱恩生物有限公司 |
具有狂犬病病毒抗原的黑猩猩腺病毒构建体
|
|
WO2018134265A1
(en)
|
2017-01-17 |
2018-07-26 |
Forrest Michael David |
Therapeutic inhibitors of the reverse mode of atp synthase
|
|
US11117930B2
(en)
|
2017-02-23 |
2021-09-14 |
Adrx, Inc. |
Peptide inhibitors of transcription factor aggregation
|
|
MX2019010275A
(es)
|
2017-02-28 |
2019-10-15 |
Univ Pennsylvania |
Novedoso vector del subtipo f del virus adenoasociado (aav) y usos de este.
|
|
BR112019017697A2
(pt)
|
2017-02-28 |
2020-04-07 |
The Trustees Of The University Of Pennsylvania |
vacinas contra influenza baseadas em vetores de vírus adenoassociado (aav)
|
|
JOP20190200A1
(ar)
|
2017-02-28 |
2019-08-27 |
Univ Pennsylvania |
تركيبات نافعة في معالجة ضمور العضل النخاعي
|
|
WO2018162748A1
(en)
*
|
2017-03-10 |
2018-09-13 |
Genethon |
Treatment of glycogen storage disease iii
|
|
JP2020512815A
(ja)
*
|
2017-04-03 |
2020-04-30 |
アメリカン ジーン テクノロジーズ インターナショナル インコーポレイテッド |
フェニルケトン尿症を処置するための組成物および方法
|
|
WO2018191450A2
(en)
|
2017-04-14 |
2018-10-18 |
National Taiwan University Hospital |
Gene therapy for aadc deficiency
|
|
EP3634978A1
(en)
|
2017-06-07 |
2020-04-15 |
Adrx, Inc. |
Tau aggregation inhibitors
|
|
JOP20190269A1
(ar)
|
2017-06-15 |
2019-11-20 |
Voyager Therapeutics Inc |
بولي نوكليوتيدات aadc لعلاج مرض باركنسون
|
|
WO2018232359A1
(en)
|
2017-06-16 |
2018-12-20 |
American Gene Technologies International Inc. |
Methods and compositions for the activation of tumor cytotoxicity via human gamma-delta t-cells
|
|
US12116577B2
(en)
*
|
2017-06-20 |
2024-10-15 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Codon-optimized human NPC1 genes for the treatment of Niemann-Pick type C1 deficiency and related conditions
|
|
RU2019143627A
(ru)
*
|
2017-06-28 |
2021-07-28 |
Юниверсити Оф Соус Флорида |
Модифицированный ген ube3a для генной терапии синдрома ангельмана
|
|
IL271845B2
(en)
|
2017-07-13 |
2024-06-01 |
Michael David Forrest |
Therapeutic modulators of the reverse mode of atp synthase
|
|
EP3655539A1
(en)
|
2017-07-21 |
2020-05-27 |
GlaxoSmithKline Biologicals S.A. |
Chikungunya virus antigen constructs
|
|
CN110945018A
(zh)
|
2017-07-27 |
2020-03-31 |
诺华股份有限公司 |
抗脱落酶的trem2变体
|
|
TWI832036B
(zh)
|
2017-08-03 |
2024-02-11 |
美商航海家醫療公司 |
用於aav之遞送之組合物及方法
|
|
BR112020002394A2
(pt)
*
|
2017-08-09 |
2020-07-28 |
Bioverativ Therapeutics Inc. |
moléculas de ácidos nucleicos e usos das mesmas
|
|
EP3697902A1
(en)
|
2017-10-16 |
2020-08-26 |
GlaxoSmithKline Biologicals S.A. |
Enhanced promoter
|
|
KR20200066349A
(ko)
|
2017-10-16 |
2020-06-09 |
글락소스미스클라인 바이오로지칼즈 에스.에이. |
복제 가능 아데노바이러스 벡터
|
|
CA3084346A1
(en)
|
2017-10-16 |
2019-04-25 |
Glaxosmithkline Biologicals Sa |
Simian adenoviral vectors with two expression cassettes
|
|
CA3079048A1
(en)
|
2017-10-16 |
2019-04-25 |
Glaxosmithkline Biologicals Sa |
Adenoviral vectors with two expression cassettes encoding rsv antigenic proteins or fragments thereof
|
|
CN111819281B
(zh)
*
|
2017-10-23 |
2024-12-31 |
普利维尔治疗公司 |
用于神经变性疾病的基因疗法
|
|
US20200283800A1
(en)
*
|
2017-10-23 |
2020-09-10 |
Prevail Therapeutics, Inc. |
Gene therapies for neurodegenerative diseases
|
|
BR112020012336A2
(pt)
|
2017-12-19 |
2021-03-30 |
Akouos, Inc. |
Administração de anticorpos terapêuticos mediada por aav para o ouvido interno
|
|
MX2020006225A
(es)
|
2017-12-20 |
2020-12-07 |
Glaxosmithkline Biologicals Sa |
Constructos antigenicos del virus de epstein-barr.
|
|
CN108103104B
(zh)
*
|
2017-12-21 |
2021-07-06 |
北京锦篮基因科技有限公司 |
一种预防和治疗脉络膜新生血管相关眼部疾病的基因药物
|
|
BR112020014404A2
(pt)
|
2018-01-17 |
2020-12-29 |
Adrenas Therapeutics, Inc. |
Terapia gênica de vírus adenoassociado para deficiência de 21-hidroxilase
|
|
MA51842A
(fr)
*
|
2018-02-14 |
2020-12-23 |
Generation Bio Co |
Vecteurs d'adn non viraux et utilisations associées pour la production d'anticorps et de protéines de fusion
|
|
WO2019199841A1
(en)
*
|
2018-04-09 |
2019-10-17 |
Cure Ahc, Inc. |
Aav-mediated delivery of atp1a3 genes to central nervous system
|
|
CN119662732A
(zh)
*
|
2018-05-08 |
2025-03-21 |
纽洛可科学有限公司 |
抗fam19a5抗体的腺相关病毒（aav）递送
|
|
EP3794126A1
(en)
|
2018-05-15 |
2021-03-24 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of parkinson's disease
|
|
WO2019222329A1
(en)
|
2018-05-15 |
2019-11-21 |
Voyager Therapeutics, Inc. |
Compositions and methods for delivery of aav
|
|
EP3793615A2
(en)
|
2018-05-16 |
2021-03-24 |
Voyager Therapeutics, Inc. |
Directed evolution of aav to improve tropism for cns
|
|
CN112638936A
(zh)
|
2018-06-12 |
2021-04-09 |
葛兰素史密丝克莱恩生物有限公司 |
腺病毒多核苷酸和多肽
|
|
KR102925832B1
(ko)
|
2018-08-09 |
2026-02-11 |
바이오버라티브 테라퓨틱스 인크. |
핵산 분자 및 비바이러스 유전자 치료를 위한 이의 용도
|
|
WO2020061079A1
(en)
|
2018-09-18 |
2020-03-26 |
California Institute Of Technology |
Engineered light-sensitive proteins
|
|
CN113383010B
(zh)
|
2018-09-28 |
2025-09-09 |
沃雅戈治疗公司 |
具有经工程化改造的启动子的共济蛋白表达构建体及其使用方法
|
|
WO2020077165A1
(en)
|
2018-10-12 |
2020-04-16 |
Voyager Therapeutics, Inc. |
Compositions and methods for delivery of aav
|
|
US11352646B2
(en)
|
2018-11-05 |
2022-06-07 |
American Gene Technologies International Inc. |
Vector system for expressing regulatory RNA
|
|
US11965172B2
(en)
|
2018-11-05 |
2024-04-23 |
California Institute Of Technology |
DNA sequence modification-based gene drive
|
|
US20200148762A1
(en)
*
|
2018-11-09 |
2020-05-14 |
Avamab Pharma Inc. |
Methods for regulating endogenous production of antibodies against infectious diseases
|
|
WO2020113199A1
(en)
|
2018-12-01 |
2020-06-04 |
International Aids Vaccine Initiative |
Recombinant hiv env polypeptides and their use
|
|
BR112021012249A2
(pt)
*
|
2019-01-04 |
2021-09-08 |
Sangamo Therapeutics, Inc. |
Métodos e composições para o tratamento da doença de fabry
|
|
WO2020150065A1
(en)
|
2019-01-14 |
2020-07-23 |
California Institute Of Technology |
Methods and compositions for modulating appetite and intake of sodium
|
|
MX2021008542A
(es)
|
2019-01-18 |
2021-11-12 |
Voyager Therapeutics Inc |
Métodos y sistemas para la producción de partículas de aav.
|
|
CN113518784A
(zh)
|
2019-01-28 |
2021-10-19 |
科巴公司 |
治疗性肽
|
|
WO2020172465A1
(en)
|
2019-02-20 |
2020-08-27 |
Duke University |
Compositions and methods for the treatment of genetic diseases
|
|
WO2020190750A1
(en)
|
2019-03-15 |
2020-09-24 |
Modernatx, Inc. |
Hiv rna vaccines
|
|
US20220227875A1
(en)
*
|
2019-05-31 |
2022-07-21 |
University Of Florida Research Foundation, Incorporated |
Vector-based therapy for thyroid disease
|
|
CN113966228A
(zh)
|
2019-06-11 |
2022-01-21 |
葛兰素史密斯克莱生物公司 |
黏膜疫苗配制剂
|
|
US20230038502A1
(en)
*
|
2019-06-11 |
2023-02-09 |
Shire Human Genetic Therapies, Inc. |
Adeno associated viral vector delivery of antibodies for the treatment of disease mediated by dysregulated plasma kallikrein
|
|
CN110423778B
(zh)
*
|
2019-07-26 |
2023-04-21 |
上海科技大学 |
一种逆行性重组2型腺相关病毒在感染螺旋神经元中的应用
|
|
JP2022545378A
(ja)
*
|
2019-08-15 |
2022-10-27 |
ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィア |
ＳＣＡ１の治療のための、導入遺伝子およびイントロン由来ｍｉＲＮＡを組み合わせた治療法
|
|
WO2021046155A1
(en)
|
2019-09-03 |
2021-03-11 |
Voyager Therapeutics, Inc. |
Vectorized editing of nucleic acids to correct overt mutations
|
|
EP4048800A1
(en)
|
2019-10-23 |
2022-08-31 |
Shire Human Genetic Therapies, Inc. |
Adeno-associated virus vectors based gene therapy for hereditary angioedema
|
|
IL294278A
(en)
*
|
2019-12-31 |
2022-08-01 |
Swanbio Therapeutics Ltd |
Improved aav-abcd1 constructs and use for the treatment or prevention of adrenoleukodystrophy (ald) and/or adrenomyeloneuropathy (amn)
|
|
WO2021169167A1
(en)
*
|
2020-02-29 |
2021-09-02 |
Nanjing GenScript Biotech Co., Ltd. |
Method for treating coronavirus infections
|
|
DE102020111571A1
(de)
|
2020-03-11 |
2021-09-16 |
Immatics US, Inc. |
Wpre-mutantenkonstrukte, zusammensetzungen und zugehörige verfahren
|
|
WO2021247995A2
(en)
|
2020-06-04 |
2021-12-09 |
Voyager Therapeutics, Inc. |
Compositions and methods of treating neuropathic pain
|
|
CN111705069A
(zh)
*
|
2020-06-19 |
2020-09-25 |
武汉纽福斯生物科技有限公司 |
一种多神经营养因子联合表达载体及其应用
|
|
BR112023001456A2
(pt)
|
2020-07-27 |
2023-04-11 |
Voyager Therapeutics Inc |
Composições e métodos para o tratamento de distúrbios neurológicos relacionados à deficiência de beta glicosilceramidase
|
|
US20230285596A1
(en)
|
2020-07-27 |
2023-09-14 |
Voyager Therapeutics, Inc |
Compositions and methods for the treatment of niemann-pick type c1 disease
|
|
WO2022060916A1
(en)
*
|
2020-09-15 |
2022-03-24 |
Regenxbio Inc. |
Vectorized antibodies for anti-viral therapy
|
|
EP4240389A4
(en)
*
|
2020-11-04 |
2025-05-28 |
The Trustees of The University of Pennsylvania |
VIRAL VECTORS ENCODING DOG INSULIN FOR THE TREATMENT OF METABOLIC DISEASES IN DOGS
|
|
IL303317A
(en)
|
2020-12-01 |
2023-07-01 |
Akouos Inc |
ANTI-NATURAL ANTIBODY STRUCTURES AND RELATED METHODS FOR THE TREATMENT OF SYMPTOMS ASSOCIATED WITH VESTIBULAR SWANNOMA
|
|
US20220186252A1
(en)
|
2020-12-16 |
2022-06-16 |
Takeda Pharmaceutical Company Limited |
Adeno associated viral vector delivery of antibodies for the treatment of disease mediated by dysregulated plasma kallikrein
|
|
WO2022157548A1
(en)
|
2021-01-24 |
2022-07-28 |
Forrest Michael David |
Inhibitors of atp synthase - cosmetic and therapeutic uses
|
|
US20240148903A1
(en)
|
2021-03-08 |
2024-05-09 |
Nanjing GenScript Biotech Co., Ltd. |
Delivery of antibody by using dual viral vector system
|
|
AR125143A1
(es)
|
2021-03-19 |
2023-06-14 |
Adrenas Therapeutics Inc |
Terapias génicas para la deficiencia de la 21-hidroxilasa
|
|
CN117940135A
(zh)
*
|
2021-08-06 |
2024-04-26 |
宾夕法尼亚大学理事会 |
用于治疗和预防错误折叠的蛋白的组合物和方法
|
|
EP4395808A4
(en)
*
|
2021-09-01 |
2025-11-19 |
Jaguar Gene Therapy Llc |
Adenine-associated vectors and virions for the treatment of galactosemia and methods of use and manufacture
|
|
CN115772520B
(zh)
*
|
2021-09-08 |
2023-11-21 |
北京锦篮基因科技有限公司 |
用于治疗庞贝氏病的基因治疗构建体、药物组合物和方法
|
|
EP4415746A1
(en)
|
2021-10-12 |
2024-08-21 |
Bridgebio Gene Therapy LLC |
Methods and compositions for treating leukodystrophies
|
|
CN114085816B
(zh)
*
|
2021-10-26 |
2023-05-26 |
四川大学华西医院 |
一种标记临近星形胶质细胞的方法
|
|
CN114107390B
(zh)
*
|
2021-11-05 |
2023-10-24 |
中国科学院精密测量科学与技术创新研究院 |
一种用于表达抗体IgG1的rAAV载体及其应用
|
|
US20250049955A1
(en)
|
2021-11-17 |
2025-02-13 |
Voyager Therapeutics, Inc. |
Compositons and methods for the treatment of neurological disorders related to glucosylceramidase beta deficiency
|
|
CN119365208A
(zh)
|
2022-04-13 |
2025-01-24 |
巴塞罗那自治大学 |
通过表达klotho蛋白的基因疗法治疗神经肌肉疾病
|
|
WO2023240236A1
(en)
|
2022-06-10 |
2023-12-14 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of spinal muscular atrophy related disorders
|
|
US20250381304A1
(en)
|
2022-06-21 |
2025-12-18 |
Crispr Therapeutics Ag |
Methods and compositions for in vivo editing of stem cells
|
|
WO2023248145A1
(en)
|
2022-06-21 |
2023-12-28 |
Crispr Therapeutics Ag |
Compositions and methods for treating human immunodeficiency virus
|
|
CN116396983A
(zh)
*
|
2022-10-10 |
2023-07-07 |
苏州吉纳星辰生物技术有限公司 |
一种检测aav抗体滴度的方法
|
|
AU2023417630A1
(en)
|
2022-12-29 |
2025-05-15 |
Voyager Therapeutics, Inc. |
Compositions and methods for regulating mapt
|
|
AU2023427408A1
(en)
|
2023-02-02 |
2025-09-04 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of neurological disorders related to glucosylceramidase beta deficiency
|
|
AU2024276475A1
(en)
*
|
2023-05-22 |
2025-09-25 |
Fred Hutchinson Cancer Center |
Treatment of hsv-2 using a meganuclease
|
|
WO2025171001A1
(en)
|
2024-02-06 |
2025-08-14 |
Regeneron Pharmaceuticals, Inc. |
Compositions and methods for improved production of aav viral vectors
|
|
CN118045206B
(zh)
*
|
2024-04-12 |
2024-07-05 |
四川至善唯新生物科技有限公司 |
一种治疗脊髓型肌肉萎缩的药物组合物及其用途
|